Clinical Trials Logo

Clinical Trial Summary

The hypothesis of this study is that DiaoShi Jifa reduces the symptoms, such as dizziness in patients with Meniere's disease.


Clinical Trial Description

Created by Dr. Diao, DiaoShi Jifa is a well-known traditional Chinese Medicine approach to treat dizziness in patients with chronic diseases. The investigators designed this randomized clinical trial to examine whether Diaoshi Jifa significantly decreases dizziness in patients with Meniere's disease. There are 2 arms in this trial: One arm is DiaoShi Jifa plus conventional Western medical treatment, another is conventional Western medical treatment only. The dizziness handicap inventory (DHI) will be used to evaluate the treatment effect. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01454726
Study type Interventional
Source Beijing Administration of Traditional Chinese Medicine Bureau
Contact
Status Completed
Phase Phase 3
Start date January 2011
Completion date November 2011

See also
  Status Clinical Trial Phase
Recruiting NCT06001593 - Modulating Auditory Symptoms and Vertigo of Meniere's Disease by Non-invasive Mastoid Electric Stimulation Phase 1/Phase 2
Completed NCT03325790 - SPI-1005 for the Treatment of Patients With Meniere's Disease Phase 2
Completed NCT02612337 - Study of OTO-104 in Subjects With Unilateral Meniere's Disease Phase 3
Completed NCT02265393 - A 1-Year Safety Study of OTO-104 in Subjects With Unilateral Meniere's Disease Located in United Kingdom Phase 2
Completed NCT02309099 - Cochlear Implantation After Labyrinthectomy or a Translabyrinthine Surgical Approach N/A
Completed NCT01412177 - OTO-104 for the Treatment of Meniere's Disease Phase 2
Terminated NCT02717442 - Study of OTO-104 in Subjects With Unilateral Meniere's Disease Phase 3
Completed NCT01084525 - OTO-104 for Meniere's Disease Phase 1
Terminated NCT02530931 - Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Patients With Meniere's Disease Phase 4
Terminated NCT02740387 - Open Label Study of OTO-104 in Subjects With Meniere's Disease Phase 2
Completed NCT02158585 - Study of Lamotrigine to Treat Ménière's Disease Phase 2
Completed NCT00145483 - Sildenafil For Meniere's Disease Phase 4
Suspended NCT04026516 - CAVA: Dizziness Trial N/A
Recruiting NCT03587701 - Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease Phase 2
Completed NCT02080312 - Magnetic Resonance Imaging Evaluation of Inner Ear Pathology Using Intra-Tympanic Contrast Agent N/A
Recruiting NCT01099046 - Stress Management Therapy for Meniere's Disease N/A
Completed NCT00160238 - Effects of Betaserc on Vestibular Compensation in Patients Suffering From Disabling Meniere's Disease and Having Undergone Vestibular Neurotomy Phase 4
Terminated NCT02706730 - A 6-Month Extension Study of OTO-104 in Meniere's Disease Phase 3
Completed NCT02718846 - Isobide Solution and Meniace Tablets Compared to Monotherapy With Meniace Tablets Phase 4
Completed NCT02603081 - Study to Evaluate SPI-1005 in Adults With Meniere's Disease Phase 1/Phase 2